GeoNova commits $10M to NovaGen ahead of Veea merger

What's the deal? GeoNova CapitalDealroom has a profile for this one. Try Dealroom →, a UAE-based investment and capital-markets firm, has committed a $10 million cornerstone investment in NovaGen Group B.V.Dealroom has a profile for this one. Try Dealroom → The convertible financing follows NovaGen's announcement of a proposed business combination with Nasdaq-listed Veea Inc.

What's the endgame? The transaction aims to create a Nasdaq-listed entity called NovaGen Health Networks. It would combine Veea's AI infrastructure with NovaGen's cellular-reprogramming and clinical capabilities.

Why now? Veea and NovaGen have signed a non-binding term sheet, targeting definitive documentation in the coming weeks. GeoNova is acting as lead investor, cornerstone institutional investor, and corporate adviser to NovaGen.

The firm structured the financing terms and is inviting co-investment from institutional and qualified investors alongside its own commitment. Robert Hamilton, managing partner of capital markets at GeoNova, said the firm is "taking NovaGen to our institutional, family-office and qualified-investor network as it moves toward definitive documentation."

What could go wrong? The proposed combination and related financing remain subject to definitive documentation, applicable approvals, and customary closing conditions.

The signal: At $10 million, the round sits in the 95th percentile of all-time convertible financings in AI, across a sample of 1,161 deals. GeoNova says it is reviewing further opportunities across healthcare, biotechnology, AI, defense, and natural resources, with a focus on Nasdaq and NYSE combinations, reverse mergers, and pre-listing convertible financings.

Image credit: NovaGen Group